Search
Now showing items 1-6 of 6
Treatment of bacterial infection with oral interferon-α
(United States. Patent and Trademark Office, 1998-10-06)
Bacterial infections are treated by the administration of alpha-interferon at a dosage of from about 0.1 to about 5 IU/lb./day such that the interferon is held in contact with the patient's oral and pharyngeal mucosae. The ...
Treatment of neoplastic disease with oral interferon
(United States. Patent and Trademark Office, 1998-10-20)
Neoplastic diseases are treated by the administration of human interferon, particularly IFN-α, at a dosage of from about 0.01 to about 5 IU/lb./day such that the interferon is held in contact with the patient's oral and ...
Treatment of viral disease with oral interferon-α
(United States. Patent and Trademark Office, 1998-11-03)
Viral infections are treated by the administration of alpha-interferon at a dosage of from about 0.01 to about 5 IU/lb./day such that the interferon is held in contact with the patient's oral and pharyngeal mucosae. The ...
Treatment of autoimmune disorders with oral interferon
(United States. Patent and Trademark Office, 1998-12-08)
Autoimmune disorders are treated by the administration of human interferon, particularly IFN-α or IFN-β, at a dosage of from about 0.01 to about 5 IU/lb./day such that the interferon is held in contact with the patient's ...
Treatment of hyperallergenic response with oral interferon
(United States. Patent and Trademark Office, 1999-03-16)
Hyperallergenic conditions are treated by the administration of interferon at a dosage of from about 0.01 to about 5 IU/lb./day such that the interferon is held in contact with the patient's oral and pharyngeal mucosae. ...
Low-dose oral administration of interferons
(United States. Patent and Trademark Office, 1999-06-08)
Improved methods for administering an interferon (IFN) to a warm-blooded vertebrate are described. The methods employ oral administration of the IFN to the vertebrate in very low dosages, for example, 0.1 to 1.5 IU per ...